BioCentury
ARTICLE | Financial News

Advent closes HCLS III fund

June 30, 2004 7:00 AM UTC

Advent International announced a $125 million final closing of its Health Care & Life Sciences III fund, which will invest in early stage healthcare companies. AstraZeneca (LSE:AZN; AZN) is a major in...